Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary? - Suppr | 超能文献

Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary?

作者信息

Smith S R, Butterly D W, Conlon P J, Harland R C, Emovon O E

机构信息

Department of Medicine, Duke University Medical Center, Durham, North Carolina, 27710 USA.

出版信息

Transplant Proc. 1998 Aug;30(5):2097-9. doi: 10.1016/s0041-1345(98)00551-x.

DOI:10.1016/s0041-1345(98)00551-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary?

Transplant Proc. 1998 Aug;30(5):2097-9. doi: 10.1016/s0041-1345(98)00551-x.

2

Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients.更昔洛韦预防免疫高风险受者原发性巨细胞病毒病失败。

Transplant Proc. 1998 Jun;30(4):1314-5. doi: 10.1016/s0041-1345(98)00256-5.

3

Long-term results and risk factors of quadruple immunosuppression in renal transplantation.

Transplant Proc. 1999 Feb-Mar;31(1-2):1111-2. doi: 10.1016/s0041-1345(98)01924-1.

4

20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.一项比较抗淋巴细胞球蛋白诱导治疗与未诱导治疗对肾移植患者疗效的随机对照试验的20年随访结果

Transplantation. 2008 Dec 27;86(12):1732-7. doi: 10.1097/TP.0b013e318190659d.

5

Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients.聚合酶链反应触发的抢先或延迟治疗以控制肾移植患者中与巨细胞病毒相关的发病率和费用

Transplant Proc. 1997 Feb-Mar;29(1-2):809-11. doi: 10.1016/s0041-1345(96)00143-1.

6

Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients.尸体肾移植受者中抗胸腺细胞球蛋白的使用与巨细胞病毒感染和/或巨细胞病毒疾病之间的关联。

Transplant Proc. 2000 Nov;32(7):1932-4. doi: 10.1016/s0041-1345(00)01499-8.

7

Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.接受诱导性抗淋巴细胞抗体治疗的肾移植受者使用更昔洛韦进行巨细胞病毒预防。

Transplant Proc. 2004 Jul-Aug;36(6):1847-9. doi: 10.1016/j.transproceed.2004.07.021.

8

Effect of antithymocyte globulin induction treatment on renal transplant outcome.抗胸腺细胞球蛋白诱导治疗对肾移植结局的影响。

Transplant Proc. 1998 Aug;30(5):1790-2. doi: 10.1016/s0041-1345(98)00433-3.

9

Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy.在接受抗淋巴细胞抗体作为诱导治疗的肾移植受者中，使用更昔洛韦或抗巨细胞病毒免疫球蛋白预防巨细胞病毒疾病。

Transplant Proc. 2002 Feb;34(1):73-4. doi: 10.1016/s0041-1345(01)02671-9.

10

Role of immunosuppressive regimen on the incidence and characteristics of cytomegalovirus infection in heart transplantation: a single-center experience with preemptive therapy.免疫抑制方案对心脏移植中巨细胞病毒感染发生率及特征的作用：抢先治疗的单中心经验

Transplant Proc. 2005 Jul-Aug;37(6):2684-7. doi: 10.1016/j.transproceed.2005.06.080.

引用本文的文献

1

Viral prophylaxis in organ transplant patients.器官移植患者的病毒预防

Drugs. 2004;64(24):2763-92. doi: 10.2165/00003495-200464240-00004.